Impact of Istradefylline on Levodopa Dose Escalation in Parkinson’s Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study

Autor: Taku Hatano, Renpei Sengoku, Hiroshi Nagayama, Naotake Yanagisawa, Asako Yoritaka, Keisuke Suzuki, Noriko Nishikawa, Yohei Mukai, Kyoichi Nomura, Norihito Yoshida, Morinobu Seki, Miho Kawabe Matsukawa, Hiroo Terashi, Katsuo Kimura, Jun Tashiro, Shigeki Hirano, Hidetomo Murakami, Hideto Joki, Tsuyoshi Uchiyama, Hideki Shimura, Kotaro Ogaki, Jiro Fukae, Yoshio Tsuboi, Kazushi Takahashi, Toshimasa Yamamoto, Kenichi Kaida, Ryoko Ihara, Kazutomi Kanemaru, Osamu Kano

Publikováno v: Neurology and Therapy, Vol 13, Iss 2, Pp 323-338 (2024)

Abstract Introduction A higher levodopa dose is a risk factor for motor complications in Parkinson’s disease (PD). Istradefylline (IST) is used as adjunctive treatment to levodopa in PD patients with off episodes, but its impact on levodopa dose ti

Externí odkaz: https://doaj.org/article/297912391b29425383cd3fe2f9e7b7d9

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123I-MIBG turnover can identify Lewy body disease

Autor: Yoshitaka Kumakura, Yuji Shimizu, Masatsugu Hariu, Ken-ichi Ichikawa, Norihito Yoshida, Masato Suzuki, Satoru Oji, Shinya Narukawa, Haruo Yoshimasu, Kyoichi Nomura

Publikováno v: EJNMMI Research, Vol 11, Iss 1, Pp 1-12 (2021)

Abstract Background Using two static scans for 123I-meta-iodobenzyl-guanidine (123I-MIBG) myocardial scintigraphy ignores the dynamic response from vesicular trapping in nerve terminals. Moreover, the long pause between scans is impractical for patie

Externí odkaz: https://doaj.org/article/7978b9caea2d4e70a5836932cc464c80

The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis

Autor: Takaya Abe, Hidenori Matsuo, Ryuzo Abe, Shinji Abe, Hiroaki Asada, Akira Ashida, Akiyasu Baba, Kei Eguchi, Yutaka Eguchi, Yoshihiro Endo, Yoshihiro Fujimori, Kengo Furuichi, Yutaka Furukawa, Mayumi Furuya, Tomoki Furuya, Norio Hanafusa, Wataru Hara, Mariko Harada‐Shiba, Midori Hasegawa, Noriyuki Hattori, Motoshi Hattori, Sumi Hidaka, Toshihiko Hidaka, Chika Hirayama, Shigaku Ikeda, Hideaki Imamura, Kazuaki Inoue, Keita Ishizuka, Kiyonobu Ishizuka, Takafumi Ito, Hitomi Iwamoto, Syoko Izaki, Maki Kagitani, Shuzo Kaneko, Naoto Kaneko, Takuro Kanekura, Kiyoki Kitagawa, Makio Kusaoi, Youwei Lin, Takeshi Maeda, Hisashi Makino, Shigeki Makino, Kenichi Matsuda, Takao Matsugane, Yusuke Minematsu, Michio Mineshima, Kenichiro Miura, Katsuichi Miyamoto, Takeshi Moriguchi, Mayumi Murata, Makoto Naganuma, Hajime Nakae, Shinya Narukawa, Atsushi Nohara, Kyoichi Nomura, Hirofumi Ochi, Atsushi Ohkubo, Takayasu Ohtake, Kazuya Okada, Tomokazu Okado, Yoshiki Okuyama, Susumu Omokawa, Satoru Oji, Norihiko Sakai, Yuichiro Sakamoto, Shigeru Sasaki, Motoyoshi Sato, Mariko Seishima, Hidetoshi Shiga, Homare Shimohata, Noriko Sugawara, Kohei Sugimoto, Yasushi Suzuki, Masato Suzuki, Takashi Tajima, Yasuhiro Takikawa, Satoru Tanaka, Kenjiro Taniguchi, Satoko Tsuchida, Tatsuo Tsukamoto, Kenji Tsushima, Yasunori Ueda, Takashi Wada, Hiromichi Yamada, Hiroyuki Yamada, Toshihiko Yamaka, Ken'ichiro Yamamoto, Yoko Yokoyama, Norihito Yoshida, Toyokazu Yoshioka, Ken Yamaji

Publikováno v: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCE. 25(6)

Most of the diseases for which apheresis therapy is indicated are intractable and rare, and each patient has a different background and treatment course prior to apheresis therapy initiation. Therefore, it is difficult to conduct large-scale randomiz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839074705f684480f34330c769c39233
https://pubmed.ncbi.nlm.nih.gov/34877777

Mean Platelet Volume Is Associated with Early Neurological Deterioration in Patients with Branch Atheromatous Disease: Involvement of Platelet Activation

Autor: Norihito Yoshida, Kyoichi Nomura, Masato Suzuki, Dembo Tomohisa, Takashi Tajima, Akane Saito, Wataru Hara, Satoru Oji

Publikováno v: Journal of Stroke and Cerebrovascular Diseases. 27:1624-1631

The most attentive clinical problem in patients with branch atheromatous disease (BAD) is early neurological deterioration (END). Although the platelet activation (PA) is involved in pathogenesis, the relationship between PA and END has remained uncl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09aeee0264989fca8821810063e4ba89
https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.01.012

Guillain-Barré syndrome initially manifesting as motor weakness, urinary dysfunction and hyperreflexia: Case report and literature review

Autor: Kenichi Kaida, Keita Ishizuka, Kyoichi Nomura, Hideki Takeshita, Kohei Sugimoto, Shinya Narukawa, Norihito Yoshida, Satoru Oji

Publikováno v: Clinical and Experimental Neuroimmunology. 9:110-114

Background Guillain–Barre syndrome (GBS) is an acute inflammatory neuropathy characterized by areflexic quadriparesis. Urinary dysfunction has been known to occur in approximately 25% of GBS patients during the clinical course and usually emerges d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b1698b369b97cd26bcf8f5cf6eced975
https://doi.org/10.1111/cen3.12425